152 related articles for article (PubMed ID: 38278599)
1. Superficial CD34-Positive Fibroblastic Tumor.
Perret R; Hostein I
Surg Pathol Clin; 2024 Mar; 17(1):1-12. PubMed ID: 38278599
[TBL] [Abstract][Full Text] [Related]
2. Superficial CD34-positive fibroblastic tumor (SCPFT): A review of pathological and clinical features.
Salah HT; D'ardis JA; Baek D; Schwartz MR; Ayala AG; Ro JY
Ann Diagn Pathol; 2022 Jun; 58():151937. PubMed ID: 35344860
[TBL] [Abstract][Full Text] [Related]
3. Superficial CD34-positive fibroblastic tumor: Cytologic features, tissue correlation, ancillary studies, and differential diagnosis of a recently described soft tissue neoplasm.
Li W; Molnar SL; Mott M; White E; De Las Casas LE
Diagn Cytopathol; 2016 Nov; 44(11):926-930. PubMed ID: 27432164
[TBL] [Abstract][Full Text] [Related]
4. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
[TBL] [Abstract][Full Text] [Related]
5. Superficial CD34 Positive Fibroblastic Tumour with Myxoid Stroma.
Bruce-Brand C; Conradie W; Schneider JW
Int J Surg Pathol; 2023 Aug; 31(5):751-754. PubMed ID: 36221951
[TBL] [Abstract][Full Text] [Related]
6. Superficial CD34 fibroblastic tumors and PRDM10-rearranged soft tissue neoplasm: An evolving diagnosis.
Johnson C; Parsa L; Gibbs J; Sligh J
J Cutan Pathol; 2024 Jan; 51(1):11-14. PubMed ID: 37150806
[TBL] [Abstract][Full Text] [Related]
7. Recurrent PRDM10 Fusions in Superficial CD34-Positive Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 10 Additional Cases of an Emerging Novel Entity.
Zhao M; Yin X; He H; Fan Y; Ru G; Meng X
Am J Clin Pathol; 2023 Apr; 159(4):367-378. PubMed ID: 36812381
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics.
Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Murahashi Y; Emori M; Tsuyuki A; Hasegawa T
Med Mol Morphol; 2023 Mar; 56(1):69-77. PubMed ID: 36344703
[TBL] [Abstract][Full Text] [Related]
9. Superficial mesenchymal tumours expressing epithelial markers on immunohistochemistry: Diagnostic clues and pitfalls.
Andrei V; Haefliger S; Baumhoer D
Semin Diagn Pathol; 2023 Jul; 40(4):238-245. PubMed ID: 37147159
[TBL] [Abstract][Full Text] [Related]
10. Superficial CD34-positive fibroblastic tumor in the forearm of a middle-aged patient: A newly described, rare soft-tissue tumor.
Rekhi B; Banerjee D; Gala K; Gulia A
Indian J Pathol Microbiol; 2018; 61(3):421-424. PubMed ID: 30004071
[TBL] [Abstract][Full Text] [Related]
11. Fine needle aspiration cytology of a superficial CD34-positive fibroblastic tumour, including differential diagnoses and recent updates.
Rekhi B
Cytopathology; 2023 Jan; 34(1):66-71. PubMed ID: 36151940
[TBL] [Abstract][Full Text] [Related]
12. Superficial CD34-Positive Fibroblastic Tumor.
Foot O; Hallin M; Bagué S; Jones RL; Thway K
Int J Surg Pathol; 2020 Dec; 28(8):879-881. PubMed ID: 32608310
[TBL] [Abstract][Full Text] [Related]
13. Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy.
Carter JM; Weiss SW; Linos K; DiCaudo DJ; Folpe AL
Mod Pathol; 2014 Feb; 27(2):294-302. PubMed ID: 23887307
[TBL] [Abstract][Full Text] [Related]
14. Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.
Puls F; Carter JM; Pillay N; McCulloch TA; Sumathi VP; Rissler P; Fagman H; Hansson M; Amary F; Tirabosco R; Magnusson L; Nilsson J; Flanagan AM; Folpe AL; Mertens F
Mod Pathol; 2022 Jun; 35(6):767-776. PubMed ID: 34969957
[TBL] [Abstract][Full Text] [Related]
15. Case of recurrent superficial CD34-positive fibroblastic tumor.
Salah HT; D'Ardis JA; Baek D; Duran J; Schwartz MR; Ayala AG; Ro JY
J Cutan Pathol; 2023 Jun; 50(6):477-480. PubMed ID: 36107756
[TBL] [Abstract][Full Text] [Related]
16. An update on selected cutaneous (myo) fibroblastic mesenchymal tumors.
Georgantzoglou N; Linos K
Semin Diagn Pathol; 2023 Jul; 40(4):295-305. PubMed ID: 37150655
[TBL] [Abstract][Full Text] [Related]
17. Superficial CD34-Positive Fibroblastic Tumor on the Chest Wall of an 8-Year-Old Girl: A Case Report and Literature Review.
Li SY; Zhang HL; Bai YZ
Pediatr Hematol Oncol; 2021 Sep; 38(6):602-608. PubMed ID: 33792506
[TBL] [Abstract][Full Text] [Related]
18. Update on Cutaneous Soft Tissue Tumors.
Dermawan JK; Ko JS; Billings SD
Surg Pathol Clin; 2021 Jun; 14(2):195-207. PubMed ID: 34023100
[TBL] [Abstract][Full Text] [Related]
19. Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases.
Anderson WJ; Mertens F; Mariño-Enríquez A; Hornick JL; Fletcher CDM
Am J Surg Pathol; 2022 Oct; 46(10):1329-1339. PubMed ID: 35713642
[TBL] [Abstract][Full Text] [Related]
20. Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.
Machado I; López-Soto MV; Rubio L; Navarro L; Llombart-Bosch A
Diagn Cytopathol; 2015 May; 43(5):421-6. PubMed ID: 25693574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
